Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Malignant Melanoma

  Free Subscription


2 Ann Surg Oncol
2 Anticancer Res
1 BMC Cancer
1 Clin Cancer Res
6 J Am Acad Dermatol
3 J Invest Dermatol
1 Melanoma Res
1 Nat Rev Cancer
1 PLoS Comput Biol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. VAN AKKOOI ACJ, Spillane AJ
    ASO Author Reflections: The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients: A Potential Paradigm Shift in Management.
    Ann Surg Oncol. 2020 May 7. pii: 10.1245/s10434-020-08570.

  2. IBRAHIM AM, Le May M, Bosse D, Marginean H, et al
    Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence.
    Ann Surg Oncol. 2020 May 3. pii: 10.1245/s10434-020-08407.
    PubMed         Abstract available

    Anticancer Res

  3. BATENI SB, Johns AJ, Gingrich AA, Gholami S, et al
    Elderly Age Is Associated With More Conservative Treatment of Invasive Melanoma.
    Anticancer Res. 2020;40:2895-2903.
    PubMed         Abstract available

  4. KOTOWSKI K, Supplitt S, Wiczew D, Przystupski D, et al
    3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.
    Anticancer Res. 2020;40:2613-2625.
    PubMed         Abstract available

    BMC Cancer

  5. WANG X, Xiong H, Liang D, Chen Z, et al
    The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients.
    BMC Cancer. 2020;20:378.
    PubMed         Abstract available

    Clin Cancer Res

  6. ALGAZI AP, Twitty CG, Tsai KK, Le M, et al
    Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma.
    Clin Cancer Res. 2020 May 6. pii: 1078-0432.CCR-19-2217.
    PubMed         Abstract available

    J Am Acad Dermatol

  7. FRIED L, Tan A, Bajaj S, Liebman TN, et al
    Technological advances for the detection of melanoma: Part II. Advances in molecular techniques.
    J Am Acad Dermatol. 2020 Apr 29. pii: S0190-9622(20)30739.
    PubMed         Abstract available

  8. ZALAUDEK I, Conforti C, Guarneri F, Vezzoni R, et al
    Clinical and dermoscopic characteristics of congenital and non-congenital nevus-associated melanomas.
    J Am Acad Dermatol. 2020 Apr 28. pii: S0190-9622(20)30737.
    PubMed         Abstract available

  9. MARCHETTI MA, Yu A, Nanda J, Tschandl P, et al
    Number Needed to Biopsy (NNB) Ratio and Diagnostic Accuracy for Melanoma Detection.
    J Am Acad Dermatol. 2020 Apr 28. pii: S0190-9622(20)30725.
    PubMed         Abstract available

  10. LI X, Kraft P, De Vivo I, Giovannucci E, et al
    Height, nevus count, and risk of cutaneous malignant melanoma: results from two large cohorts of US women.
    J Am Acad Dermatol. 2020 May 3. pii: S0190-9622(20)30783.
    PubMed         Abstract available

  11. BARRIERA-SILVESTRINI P, Xiong DD, Lewis S, Knackstedt T, et al
    Melanoma Incidence and Survival in Patients with Myelodysplastic Syndrome: A Matched Cohort Population-Based Study.
    J Am Acad Dermatol. 2020 May 3. pii: S0190-9622(20)30770.

  12. SANCHEZ DP, Maymone MBC, McLean EO, Kennedy KF, et al
    Racial and Ethnic disparities in Melanoma Awareness: A Cross-Sectional Survey.
    J Am Acad Dermatol. 2020 May 4. pii: S0190-9622(20)30758.
    PubMed         Abstract available

    J Invest Dermatol

  13. ADAM C, Fusi L, Weiss N, Goller SG, et al
    Efficient suppression of NRAS-driven melanoma by co-inhibition of ERK1/2 and ERK5 MAPK pathways.
    J Invest Dermatol. 2020 May 3. pii: S0022-202X(20)31407.
    PubMed         Abstract available

  14. AVITAN-HERSH E, Feng Y, Vaisman AO, Ahmed YA, et al
    Regulation of eIF2alpha by RNF4 promotes melanoma tumorigenesis and therapy resistance.
    J Invest Dermatol. 2020 Apr 29. pii: S0022-202X(20)31404.
    PubMed         Abstract available

  15. TIFFEN J, Gallagher S, Filipp F, Gunatilake D, et al
    EZH2 cooperates with DNA methylation to downregulate key tumour suppressors and interferon gene signatures in melanoma.
    J Invest Dermatol. 2020 Apr 29. pii: S0022-202X(20)31390.
    PubMed         Abstract available

    Melanoma Res

  16. AUDREY-BAYAN C, Trager MH, Gartrell-Corrado RD, Rizk EM, et al
    Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec.
    Melanoma Res. 2020 Apr 22. doi: 10.1097/CMR.0000000000000661.
    PubMed         Abstract available

    Nat Rev Cancer

  17. SHAIN AH, Bastian BC
    Author Correction: From melanocytes to melanomas.
    Nat Rev Cancer. 2020 May 7. pii: 10.1038/s41568-020-0269.
    PubMed         Abstract available

    PLoS Comput Biol

  18. COMANDANTE-LOU N, Khaliq M, Venkat D, Manikkam M, et al
    Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy.
    PLoS Comput Biol. 2020;16:e1007688.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.